Are you Dr. Ishizawa?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 7 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Education & Training
Keio Gujuku University School of MedicineClass of 2004
Certifications & Licensure
TX State Medical License 2021 - 2025
Publications & Presentations
PubMed
- 44 citationsBETP degradation simultaneously targets acute myelogenous leukemic stem cells and the microenvironmentSujan Piya, Hong Mu, Seemana Bhattacharya, Philip L. Lorenzi, R. Eric Davis
The Journal of Clinical Investigation. 2019-05-01 - 106 citationsDiscovery and clinical introduction of first-in-class imipridone ONC201Joshua E. Allen, C. Leah B. Kline, Varun V. Prabhu, Jessica Wagner, Jo Ishizawa
Oncotarget. 2016-09-01 - 17 citationsInhibition of translation initiation factor eIF4a inactivates heat shock factor 1 (HSF1) and exerts anti-leukemia activity in AML.Yuki Nishida, Ran Zhao, Lauren Heese, Hiroki Akiyama, Shreya Patel
Leukemia. 2021-06-14
